(Q37111783)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Dario Giugliano

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

E Razzoli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

K Esposito

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

199-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia

4 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00044011-200828040-00001

Acute hyperglycemia induces an oxidative stress in healthy subjects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00044011-200828040-00001

Strategies for insulin therapy in type 2 diabetes

21 January 2018

1 reference

12 December 2020

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

12 December 2020

The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

1 reference

12 December 2020

Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.

1 reference

12 December 2020

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week

1 reference

12 December 2020

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

12 December 2020

Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus

1 reference

12 December 2020

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

12 December 2020

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

1 reference

12 December 2020

Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

1 reference

12 December 2020

Insulin analogues in the management of diabetes.

1 reference

12 December 2020

Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group

1 reference

12 December 2020

Controlling postprandial hyperglycemia

1 reference

12 December 2020

Standards of medical care in diabetes--2006

1 reference

12 December 2020

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

1 reference

12 December 2020

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

1 reference

12 December 2020

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

12 December 2020

Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure

1 reference

12 December 2020

Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group

1 reference

12 December 2020

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

1 reference

12 December 2020

Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits

1 reference

12 December 2020

Insulin glargine: an updated review of its use in the management of diabetes mellitus

1 reference

12 December 2020

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

1 reference

12 December 2020

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

1 reference

12 December 2020

Insulin lispro: a review of its use in the management of diabetes mellitus

1 reference

12 December 2020

Targeting postprandial hyperglycemia

1 reference

12 December 2020

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999

1 reference

12 December 2020

How well do rapid-acting insulins work in obese individuals?

1 reference

12 December 2020

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

1 reference

12 December 2020

The postprandial state and the risk of atherosclerosis

1 reference

12 December 2020

A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents

1 reference

12 December 2020

Insulin detemir: a new basal insulin analogue

1 reference

12 December 2020

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

1 reference

12 December 2020

Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?

1 reference

12 December 2020

A desktop guide to Type 1 (insulin-dependent) diabetes mellitus. European Diabetes Policy Group 1998

1 reference

12 December 2020

1 reference

12 December 2020

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

1 reference

12 December 2020

Clinical significance, pathogenesis, and management of postprandial hyperglycemia

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Postprandial hyperglycemia: implications for practice

1 reference

12 December 2020

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

1 reference

12 December 2020

A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus

1 reference

12 December 2020

The clinical importance of postprandial glucose

1 reference

12 December 2020

Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients.

1 reference

12 December 2020

A review of human and analogue insulin trials

1 reference

12 December 2020

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes

1 reference

12 December 2020

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

12 December 2020

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

1 reference

12 December 2020

The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.

1 reference

12 December 2020

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

1 reference

12 December 2020

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.

1 reference

12 December 2020

Postprandial glucose regulation: new data and new implications

1 reference

12 December 2020

The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications

1 reference

12 December 2020

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

12 December 2020

10.2165/00044011-200828040-00001

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345710%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference